Menu
Donovan Leung
Investment Manager
Donovan joined the Rosetta investment team in 2022 as an Associate. Prior to Rosetta, Donovan advised on healthcare M&A transactions at a boutique investment bank and was a strategy consultant at IQVIA in the financial institutions team. He has been involved with over 30 transactions with a notional value of over $20 billion.
Prior to his roles in business, Donovan was involved in the discovery of novel compounds from animal venoms and has a BSc honours degree in biochemistry from the University of Liverpool.
Meet more of our people
